Back to Search Start Over

Review on current treatment options for lesions of uncertain malignant potential (B3 lesions) of the breast: do B3 papillary lesions need to be removed in any case by open surgery?

Review on current treatment options for lesions of uncertain malignant potential (B3 lesions) of the breast: do B3 papillary lesions need to be removed in any case by open surgery?

Authors :
Bekes I
deGregorio A
deWaal A
Nerlich A
deWaal J
Janni W
Ebner F
Source :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2019 Aug; Vol. 300 (2), pp. 481-484. Date of Electronic Publication: 2018 Nov 26.
Publication Year :
2019

Abstract

Background: In breast tissue, pre-malignant lesions are classified as BIRADS 3. The treatment of this heterogeneous group varies with expertise and tools available.<br />Materials and Methods: With the example of two case reports, the literature is reviewed on current treatment options for BIRADS 3 breast lesions.<br />Results: About 7% of all B-type breast biopsies fall into the B3 category. Approximately 35% of these B3 lesions are due to FEA, 20% to PLs and another 20% to ADH. Due to improvement in diagnostics, the incidence is increasing, while their value as a predictive factor for malignancy has steadily been fallen.<br />Conclusion: Depending on the histology of the needle biopsy, a complete resection with vacuum-assisted biopsy may be a treatment alternative to open biopsy.

Details

Language :
English
ISSN :
1432-0711
Volume :
300
Issue :
2
Database :
MEDLINE
Journal :
Archives of gynecology and obstetrics
Publication Type :
Review
Accession number :
30474713
Full Text :
https://doi.org/10.1007/s00404-018-4985-0